News

Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Q1 2025 Earnings Call Transcript
Q1 2025 Earnings Call Transcript May 14, 2025 Monogram Orthopaedics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.12. Larry Holub: Good afternoon, everyone, and ...
Monogram Technologies Reports First Quarter 2025 Financial Results
Receives FDA Clearance for the mBôsTM TKA System Groundbreaking Trial Set to Deliver one of the World's First Autonomous Saw-Based Robotic ...
MGRM: The De-Risking of the Monogram Story from FDA Clearance and Initiation of Live Patient Trials Supports Price Target of $6.00
MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 1 st quarter 2025 financial results on May 14, 2025 which were largely in line with our expectations. Research and development ...
Monogram Technologies Inc.: Monogram Technologies Reports First Quarter 2025 Financial Results
Receives FDA Clearance for the mBôs TKA System Groundbreaking Trial Set to Deliver one of the World's First Autonomous Saw-Based Robotic TKA Surgeries on Live Patients Management to Host Business Upda ...